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Abstract. A new complex of palladium was isolated with 2-furoic hydrazide (FH) and characterized by 
spectroscopic methods. The results show that the ligand is coordinated to palladium by the basic nitrogen 
of NH2 group and has a general structure of type cis-[Pd(FH)2Cl2]. The structure of palladium(II) complex 
was optimized and theoretical data show good agreement with the experimental results. The cytotoxic  
activity was evaluated in a chronic myelogenous leukemia cell line, which revealed that the compound is 
less active than cisplatin or carboplatin. At 300 g mL−1, the complex presented antimicrobial activity 
more efficient than ampicillin, chloranfenicol and kanamicyn. (doi: 10.5562/cca2151)  
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INTRODUCTION 
The hydrazide properties are of major interest due to 
their biological activities. Hydrazides have been  
demonstrated to possess, among other, antibacterial, 
antifungical, and antitumoral activities. For example, 
isonicotinic acid hydrazide (isoniazid) exhibited high in 
vivo inhibitory activity towards M. tuberculosis 
H37Rv.1  
The formation of metallic complexes plays an im-
portant role in the growth of their biological activity1–4 
and, therefore, many complexes of hydrazides have 
been synthesized and characterized.5–7 Some of these 
metallic complexes also exhibit good fungicide, 
antitumoral and antibacterial activity.8−11 As example, 
platinum complexes containing hydrazides derived from 
benzoic acid showed strong growth inhibitory effect in 
leukemia cells in vitro, not verified with the free  
ligands.9 
On the other hand, palladium complexes have 
been obtained aiming to produce drugs, due to its 
chemical similarity with platinum, and the fact that they 
showed excellent antitumoral and anti infective activi-
ties in vitro and in vivo.12 For example, our research 
group showed that the palladium(II) complex of tetracy-
cline is 16 times more potent than free tetracycline 
against E. coli HB101/pBR322, a bacterial strain resis-
tant to tetracycline.13 In addition, this complex displays 
a significant cytotoxic activity.14 These observations 
encouraged us to synthesize new palladium complexes 
as possible antitumoral and antibacterial agents. In this 
work, we report the synthesis and characterization of a 
new palladium(II) compound with 2-furoic hydrazide. 
The compound was characterized by 1H NMR, IR,  
UV-Vis, thermal (TG/DTA), elemental and theoretical 
analysis. The cytotoxic and antibacterial activity of the 
synthesized compound was evaluated. 
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EXPERIMENTAL 
Physical Measurements 
Conductivity study was carried out with a Digimed DM 
32 conductivity meter using a cell of constant 1.00 cm−1, 
spectroscopic grade dimethylformamide (Merck)  
(M = 1.20 μs cm−1) and tetraethylammonium bromide 
(M = 78.39 μs cm−1) as a standard.  
Elemental analyses were performed at the Analyt-
ical Central of the University of São Paulo, using a 
Perkin-Elmer 2400 CHN Elemental Analyser. 
IR spectra were registered in KBr pellets on a 
Shimadzu FTIR-Irprestige-21 spectrometer. 
A spectrophotometer UV-2501 PC Shimadzu was 
used for UV and visible absorption measurements. 
NMR spectra were obtained using a Bruker 
Avance DPX 200 spectrometer with tetramethylsilane 
as an internal standard. 
Thermogravimetric analyses (TG/DTA) were  
performed on a TGA-50 Shimadzu, using 6.0 mg  
sample packed in aluminum crucible. The samples were 
heated at 10 °C min−1 from room temperature to  
500 °C, in a dynamic nitrogen atmosphere (flow rate = 
200 mL min−1). 
 
Theoretical Details  
Geometry optimization and vibrational frequency calcu-
lations were performed at MP2 and DFT level of theory 
in Gaussian 03,15 while TD-DFT/B3LYP UV-visible 
spectra were computed in Orca program package.16 For 
optimization and frequency calculations, the LANL2DZ 
atomic basis set and effective core potential17 were used 
for the metal center, while the standard 6-311++G(d,p) 
basis sets were employed for the other atoms.18 The 
electronic spectrum was computed at B3LYP level, with 
def2-SVP basis set for all atoms.19 No symmetry  
restrictions have been imposed during the geometry 
optimizations. 
 
Cells and Culture 
The K562 cell line was purchased from the Rio de 
Janeiro Cell Bank (number CR083 of the RJCB collec-
tion). This cell line was established from pleural effu-
sion of a 53 year-old female with chronic myelogenous 
leukemia in terminal blast crisis. Cells were cultured in 
RPMI 1640 (Sigma Chemical Co.) medium supple-
mented with 10 % fetal calf serum (CULTILAB, São 
Paulo, Brazil) at 37 °C in a humidified 5 % CO2 atmos-
phere. Cultures grow exponentially from 105 cells mL−1 
to about 8×105 cells mL−1 in three days. Cell viability 
was checked by Trypan Blue exclusion. The cell  
number was determined by Coulter counter analysis.  
The cytotoxic effect was evaluated by incubating  
1×105 cells mL−1 in the absence and the presence of a 
range of concentrations of tested compounds for 72 h. 
Afterwards, cells were counted and the concentration 
required to inhibit cellular growth by 50 %, the IC50, 
was calculated. Stock solutions of the compounds were 
prepared in DMSO (2 %) and H2O. 
 
Antimicrobial Activity 
An oxaciclin-resistant Escherichia coli strain and a 
methicilin-resistant Staphylococcus aureus strain were 
used to evaluate the antimicrobial activity of the  
complex. Both strains were isolated from Uberlândia 
Federal University Hospital (HCU/UFU, Uberlândia, 
MG, Brazil). 100 µL of a suspension of each strain 
previously cultured at 37 °C in LB (NaCl 10 g L−1; 
Yeast extract 5 g L−1; Triptone 10 g L−1) were used to 
obtain an OD600 = 0,35 LB culture. The complex was 
added to each culture and the bacterial growth was  
monitored by optical density observation at 0; 6; 12; 24; 
48; and 72 hours. The complex was tested at the con-
centrations of 100 µg mL−1; 200 µg mL−1; 300 µg mL−1;  
500 µg mL−1 and 1000 µg mL−1. Each test was replicat-
ed 4 times. 
 
Starting Materials 
The reagents K2PdCl4 and 2-furoic hydrazide (FH) are 
commercially available (Aldrich). All other reagents 
chemicals were of analytical grade, purchased from 
different sources, and used without further purification. 
 
Preparation of the Complex 
0.1632 g of K2PdCl4 (0.5 mmol) was added to 5 mL of 
an aqueous solution of FH (1.0 mmol) and the mixture 
was stirred for 24 h. The solid formed was separated by 
filtration, washed with water, and dried under vacuum. 
Yield: 91 %. Color: Yellow. Anal. Calcd. for 
[Pd(C5N2O2H5)2Cl2]: C, 27.96; H, 2.82; N, 13.04 %; 
Found: C, 27.92; H, 2.78; N, 12.98 %. IR spectra in 
KBr, (cm−1): 3295, 3256, 3197, 3086, 1661, 1596, 
1562, 1526, 1469, 1316, 1253, 1234, 1180, 1144, 1016, 
953, 884, 865, 773, 751, 640, 541, 505, 498, 417. RMN 
de 1H (200 MHz; DMSO-d6):  6.91 (s, 2H, -NH2);  

















Figure 1. 2-furoic hydrazide and its palladium complex.  
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RESULTS AND DISCUSSION 
A new complex containing 2-furoic hydrazide (FH) as 
ligand was synthesized by the slow addition of the cor-
responding ligand to K2PdCl4 dissolved in water. After 
24 hours, the compound was isolated by simple filtra-
tion. The complex was characterized by elemental 
analysis, thermal analysis, IR, UV-Vis and 1H NMR. 
In this work, the ligand acts as a monodentate lig-
and replacing two Cl ligands from the precursor. The 
palladium complex is soluble in organic solvents such 
as DMSO and DMF. The chemical structures of the 
ligand (FH) and its complex (PdFH) are presented in 
Figure 1. 
The results of the elemental analysis (C, N, and H) 
are in accordance with the proposed structure. 
The freshly prepared DMF solution of the  
complex exhibited molar electric conductivity value far 
below that of the 1 : 1 standard electrolyte indicating 
that the complex is not charged.20 
 
Thermal Analysis  
The thermal stability of the complex was followed in 
the temperature range 25–500 ºC. The TG/DTA curve 
for complex (Figure 2) shows a series of events weight 
loss at 170–408 °C range that is attributed to thermal 
decomposition of the complex. At 420 °C there is a 
residue (elemental palladium) corresponding to 24.90 % 
(Calculated: 24.77 %), confirming the structure  




The IR spectrum of the free ligand was performed just 
for comparison to the corresponding complex isolated. 
The characteristic absorptions in the 3400 to 3032 cm−1 
region were observed, corresponding to NH2), 
NH), and CH). The spectrum also exhibited bands 
at 1657 and 1633 cm−1, assigned to C=O) and 
(C=C), respectively.7 
In the IR spectrum of the complex, the bands due 
NH2) were found to be shifted towards lower wave-
numbers (Figure 3). This shift can be attributed to par-
ticipation of the NH2 group in the coordination to the 
palladium ion. In addition, in the IR spectrum of the 
complex, a new peak assigned to (M−N) appeared at 
541 cm−1, indicating formation of the M−N bond (Fig-
ure 4). Another observation is that the C=O) of the 
carbonyl group appears almost in the same wavenumber 
of the ligand, therefore, we ruled out an involvement of 
this group in the coordination to the metallic ion. 
 
1H NMR  
The 1H NMR spectra of the complex and of the 2-furoic 
hydrazide ligand were recorded in d6-DMSO. 
In the spectra of the free ligand, the NH2 protons 
appear as a singlet at  4.42. This signal has been shift-
ed downfield in the complex ( 6.91) and this result 
suggests that the nitrogen of the NH2 group is involved 
in the coordination sphere.8 
The complex shows a singlet near at  9.60 ppm 
due to the NH proton. The signal of the NH proton was 
much less affected when compared to the group NH2 
Figure 2. TG/DTA curve for complex PdFH.  
Figure 3. IR spectra (3600 – 3000 cm−1) of FH (in red) and its
complex.  
Figure 4. IR spectra (640–440 cm−1) of FH (in red) and its
complex. 
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protons excluding the participation this group in the 
coordination. Thus, considering ours spectral results, we 
propose the coordination of metallic ion via NH2 group. 
The same coordination mode here proposed was  
observed in previous works for some complexes  
containing hydrazides as ligands.9,21−25 
 
Computational Results 
The MP2 and B3LYP bond lengths and bond angles of 
the palladium(II) complex optimized are collected in 
Table 1. The optimized structure of complex is shown in 
Figure 5. The results indicate that the coordination 
sphere of the complex around metal center is a distorted 
square-planar. The molecular distortion of palladium(II) 
complex can be visualized by the bite Cl−Pd−Cl and 
N−Pd−N angles, which are computed to be 99o (97o) 
and 89o (89o) at MP2(B3LYP) theory levels, respective-
ly. A rather small difference can be observed between 
results of the bond lengths and bond angles at MP2 and 
B3LYP levels. The largest deviation of 0.1 Å is  
observed in Pd−N bond length, while the value of  
1.8 degree is observed in the Cl−Pd−Cl bond angle. 
The experimental and computed Td-DFT absorp-
tion spectra of 2-furoic hydrazide ligand and its palladi-
um(II) complexes are displayed in the Figure 6. The 
experimental UV-visible absorption spectrum of the 
ligand (Figure 6) exhibit two bands centered at 220 nm 
and 251 nm, while the spectrum of the complex exhibit-
ed three peaks in the ultraviolet region. As shown in 
computed spectrum of the ligand, Td-DFT/B3LYP 
calculations in the gas-phase provide a very good  
description of the spectral profile and the absorption 
positions of the excitation electronic energies of the 
hydrazide ligand. Two more intense bands are calculat-
ed to be at 227 nm and 248 nm, in good agreement with 
the experimental measurements (220 nm and 251 nm). 
The computed spectral profile of the palladium complex 
shows a good agreement with experimental spectrum. 
However, regarding the absorption positions, the exper-
imental bands are localized at 255, 308 and 344 nm, 
while the computed positions are at 409, 448 and  
483 nm, respectively. These large solvatochromic shifts 
should be owing to the solvent effects, which are not 
taken into account in our calculations. It is worth noting 
that the experimental measurements (Figure 6) were 
done in the methanol solution and large solvatochromic 
shifts are verified for absorption spectra varying the 
basicities of solvents. It is important to note that similar 
large solvatocromic shifts have been already observed 
in some absorption spectra of the other planar TM  
complexes when solvents with different basicities are 
taken into account.26 Regarding the assignment of the 
electronic spectrum of the palladium (II) complex the 
theoretical results confirm that the experimental band at 
255 nm is assignable to intraligand π→π* transitions, 
while the band centered at 344 nm is assigned to metal-
to-ligand charge-transfer. The Figure 7 shows the  
HOMO−1 and LUMO+1 molecular orbitals which are 
involved in the latter electronic transition. Overall, the 
computational results show a good agreement with 
Table 1. The MP2 and B3lYP optimized bond lengths (Å) and 
bond angles (degree) 













































Figure 5. The optimized structure of the palladium (II) com-
plex. Molecule displayed in a ball-and-sick model (atoms are 
color coded as gray: carbon; blue: nitrogen, red: oxygen; 
green: chlorine, and white: hydrogen). 
Figure 6. Experimental and computed UV-Vis spectra of the
ligand and its palladium (II) complex. (A) Experimental 
measured in methanol (10−4 mol L−1) and (B) The computed 
spectra in the gas-phase. 
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experimental data, thus confirming that the ligand is 
coordinated to palladium by the basic nitrogen of NH2 
group and have the general structure cis-[Pd(FH)2Cl2]. 
 
Cytotoxic Activity  
The cytotoxic activity of the ligand (FH) and its  
complex was examined on K562 cells. In Table 2, IC50 
values obtained for cisplatin, the free ligand and its 
complex are shown for the sake of comparison. The 
complex PdFH inhibits the growth of K562 cells and, its 
activity is 2-fold higher than of the corresponding free 
ligand. However, in comparison to cisplatin or  
carboplatin, the effect of the complex is much lower. 
 
Antibacterial Activity  
Antimicrobial activity against two bacterial species 
belonged to main bacterial group was tested:  the Gram-
positive Staphylococcus aureus, and the Gram-negative 
Escherichia coli. The results showed that the complex 
presented antimicrobial activity against S. aureus from 
concentrations of 300 g mL−1 (Figure 8A). On the 
other hand, this activity was not observed against E. coli 
(Figure 8B). Thus, the complex presented antimicrobial 
activity against Gram-positive, but was not effective 
against Gram-negative bacteria. However, more detailed 
studies have done to evaluate the action spectrum of this 
complex against Gram-positive bacteria. The antimicro-
bial activity of complex against S. aureus was compared 
to ampicillin,28 chloranfenicol and kanamicyn.29,30  
Figure 7. (A) HOMO and (B) LUMO Kohn-Sham orbitals. 
Table 2. IC50 values for the complex and free ligand 
Compound IC50
(a) (mol L−1 ± s.d.)
FH 455.6 ± 20
[Pd(FH)2Cl2] 255.9 ± 13
carboplatin 60(b) 
cisplatin 1.1 ± 0.1
(a) IC50 is the concentration required to inhibit 50 % of cell 
growth, after 3 days of incubation. The values are the mean of 
triplicate determinations. 
(b) Value from reference 27. 
Figure 8. (A) Staphylococcus aureus growth after 6 hours of ligand and complex addition at 0, 100, 200, 300, 500, 700, and,
1000 g mL−1. (B) Escherichia coli after 6 hours of ligand and complex addition at 0, 100, 200, 300, 500, 700, and,
1000 g mL−1. (C) Staphylococcus aureus growth after ligand, complex, chloranfenicol, kanamicyn, and, ampicillin. Binder:
300 g mL−1; Complex: 300 g mL−1; Chloranfenicol: 100 g mL−1; Kanamicyn: 100 g mL−1; Control: S. aureus culture.
(D) Staphylococcus aureus growth after binder, complex, chloranfenicol, kanamicyn, and, ampicillin at 100 g mL−1. 
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At 300 µg mL−1, the complex presented antimicrobial  
activity more efficient than ampicillin, chloranfenicol 
and kanamicyn, and this activity was observed to  
72 hours (Figure 8C). However, when the complex was 
used at 100 µg mL−1 (the same concentration of the 
antimicrobials) the antimicrobial activity was observed 
only after 24 hours (Figure 8D). The results suggested 
that the complex presented a stable antimicrobial activi-
ty against Gram-positive bacteria at 300 µg mL−1. 
 
CONCLUSION 
A new complex containing 2-furoic hydrazide was pre-
pared and characterized by thermal and spectroscopic 
techniques. The spectroscopic and theoretical tech-
niques show that the ligand is coordinated to the palla-
dium by the basic nitrogen of NH2 group. 
The biological studies showed that the complex 
has a poor cytotoxic activity against K562 cell line, but 
it is active against Gram-positive bacteria. 
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